{"id":4420,"date":"2024-12-30T10:47:30","date_gmt":"2024-12-30T07:47:30","guid":{"rendered":"https:\/\/nahrainveterinary.com\/?p=4420"},"modified":"2024-12-30T10:59:03","modified_gmt":"2024-12-30T07:59:03","slug":"innovations-in-poultry-vaccine-development-addressing-challenges-in-stability-efficacy-and-delivery-through-biotechnological-advances","status":"publish","type":"post","link":"https:\/\/nahrainveterinary.com\/ar\/innovations-in-poultry-vaccine-development-addressing-challenges-in-stability-efficacy-and-delivery-through-biotechnological-advances\/","title":{"rendered":"\u0627\u0644\u0627\u0628\u062a\u0643\u0627\u0631\u0627\u062a \u0641\u064a \u062a\u0637\u0648\u064a\u0631 \u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062f\u0648\u0627\u062c\u0646: \u0645\u0639\u0627\u0644\u062c\u0629 \u062a\u062d\u062f\u064a\u0627\u062a \u0627\u0644\u0627\u0633\u062a\u0642\u0631\u0627\u0631 \u0648\u0627\u0644\u0643\u0641\u0627\u0621\u0629 \u0648\u0627\u0644\u062a\u0648\u0635\u064a\u0644 \u0645\u0646 \u062e\u0644\u0627\u0644 \u0627\u0644\u062a\u0642\u062f\u0645 \u0641\u064a \u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629"},"content":{"rendered":"

\u0627\u0644\u0627\u0628\u062a\u0643\u0627\u0631\u0627\u062a \u0641\u064a \u062a\u0637\u0648\u064a\u0631 \u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062f\u0648\u0627\u062c\u0646: \u0645\u0639\u0627\u0644\u062c\u0629 \u062a\u062d\u062f\u064a\u0627\u062a \u0627\u0644\u0627\u0633\u062a\u0642\u0631\u0627\u0631 \u0648\u0627\u0644\u0643\u0641\u0627\u0621\u0629 \u0648\u0627\u0644\u062a\u0648\u0635\u064a\u0644 \u0645\u0646 \u062e\u0644\u0627\u0644 \u0627\u0644\u062a\u0642\u062f\u0645 \u0641\u064a \u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629<\/p>\n

 <\/p>\n

\"\"<\/p>\n

\u062f. \u0645\u0627\u062c\u062f \u062d\u0645\u06cc\u062f \u0627\u0644\u0635\u0627\u06cc\u063a \/ \u0627\u062e\u062a\u0635\u0627\u0635 \u0627\u0645\u0631\u0627\u0636 \u0627\u0644\u062f\u0648\u0627\u062c\u0646 \/ \u0627\u0633\u062a\u0631\u0627\u0644\u06cc\u0627<\/p>\n

 <\/p>\n

\u0627\u0644\u0645\u0644\u062e\u0635<\/p>\n

\u062a\u0644\u0639\u0628 \u0635\u0646\u0627\u0639\u0629 \u0627\u0644\u062f\u0648\u0627\u062c\u0646 \u062f\u0648\u0631\u064b\u0627 \u062d\u064a\u0648\u064a\u064b\u0627 \u0641\u064a \u062a\u062d\u0642\u064a\u0642 \u0627\u0644\u0623\u0645\u0646 \u0627\u0644\u063a\u0630\u0627\u0626\u064a \u0627\u0644\u0639\u0627\u0644\u0645\u064a\u060c \u0644\u0643\u0646\u0647\u0627 \u062a\u0648\u0627\u062c\u0647 \u062a\u062d\u062f\u064a\u0627\u062a \u0645\u0633\u062a\u0645\u0631\u0629 \u0646\u062a\u064a\u062c\u0629 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u0639\u062f\u064a\u0629 \u0627\u0644\u062a\u064a \u062a\u0642\u0644\u0644 \u0627\u0644\u0625\u0646\u062a\u0627\u062c\u064a\u0629 \u0648\u062a\u0632\u064a\u062f \u0627\u0644\u062e\u0633\u0627\u0626\u0631 \u0627\u0644\u0627\u0642\u062a\u0635\u0627\u062f\u064a\u0629. \u0644\u0642\u062f \u0623\u062d\u062f\u062b\u062a \u0627\u0644\u062a\u0642\u062f\u0645\u0627\u062a \u0627\u0644\u0623\u062e\u064a\u0631\u0629 \u0641\u064a \u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 (Biotechnology) \u062b\u0648\u0631\u0629 \u0641\u064a \u062a\u0637\u0648\u064a\u0631 \u0648\u0627\u0633\u062a\u0642\u0631\u0627\u0631 \u0648\u062a\u0648\u0635\u064a\u0644 \u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062f\u0648\u0627\u062c\u0646. \u064a\u062a\u0646\u0627\u0648\u0644 \u0647\u0630\u0627 \u0627\u0644\u062a\u0642\u0631\u064a\u0631 \u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u0631\u0627\u0647\u0646\u0629 \u0644\u062a\u0637\u0648\u064a\u0631 \u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062f\u0648\u0627\u062c\u0646\u060c \u0645\u0639 \u0627\u0644\u062a\u0631\u0643\u064a\u0632 \u0639\u0644\u0649 \u062f\u0648\u0631 \u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0641\u064a \u0627\u0644\u062a\u063a\u0644\u0628 \u0639\u0644\u0649 \u0627\u0644\u062a\u062d\u062f\u064a\u0627\u062a \u0627\u0644\u062a\u0642\u0644\u064a\u062f\u064a\u0629 \u0645\u062b\u0644 \u0627\u0644\u062a\u0646\u0648\u0639 \u0627\u0644\u0645\u0633\u062a\u0636\u062f\u064a (Antigenic variability)\u060c \u0648\u0639\u062f\u0645 \u0627\u0633\u062a\u0642\u0631\u0627\u0631 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a (Vaccine instability)\u060c \u0648\u0642\u0644\u0629 \u0627\u0644\u0645\u0646\u0627\u0639\u0629 \u0627\u0644\u0645\u0643\u062a\u0633\u0628\u0629 (Limited immunogenicity) . \u0643\u0645\u0627 \u064a\u0633\u062a\u0639\u0631\u0636 \u0647\u0630\u0627 \u0627\u0644\u062a\u0642\u0631\u064a\u0631 \u0627\u0644\u0625\u0646\u062c\u0627\u0632\u0627\u062a \u0627\u0644\u062d\u062f\u064a\u062b\u0629 \u0645\u062b\u0644 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0645\u0646 \u0627\u0644\u062c\u064a\u0644 \u0627\u0644\u062b\u0627\u0644\u062b (Third-generation vaccines) \u0648 \u0627\u0644\u0645\u062d\u0641\u0632\u0627\u062a \u0627\u0644\u062c\u062f\u064a\u062f\u0629 (Novel adjuvants) \u0648 \u0622\u0644\u064a\u0627\u062a \u0627\u0644\u062a\u0648\u0635\u064a\u0644 \u0627\u0644\u0645\u0628\u062a\u0643\u0631\u0629 (Innovative delivery mechanisms)\u060c \u0628\u0627\u0644\u0625\u0636\u0627\u0641\u0629 \u0625\u0644\u0649 \u0625\u062a\u062c\u0627\u0647\u0627\u062a \u0627\u0644\u0628\u062d\u062b \u0627\u0644\u0645\u0633\u062a\u0642\u0628\u0644\u064a\u0629.<\/p>\n

 <\/p>\n

\u0645\u0642\u062f\u0645\u0629<\/p>\n

\u062a\u0639\u062a\u0628\u0631 \u062a\u0631\u0628\u064a\u0629 \u0627\u0644\u062f\u0648\u0627\u062c\u0646 \u0639\u0646\u0635\u0631\u064b\u0627 \u0623\u0633\u0627\u0633\u064a\u064b\u0627 \u0641\u064a \u0627\u0644\u0646\u0638\u0645 \u0627\u0644\u063a\u0630\u0627\u0626\u064a\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\u064a\u0629\u060c \u062d\u064a\u062b \u062a\u0648\u0641\u0631 \u0628\u0631\u0648\u062a\u064a\u0646\u064b\u0627 \u0645\u064a\u0633\u0648\u0631 \u0627\u0644\u062a\u0643\u0644\u0641\u0629 \u0644\u0645\u0644\u064a\u0627\u0631\u0627\u062a \u0627\u0644\u0623\u0634\u062e\u0627\u0635 \u062d\u0648\u0644 \u0627\u0644\u0639\u0627\u0644\u0645. \u0648\u0645\u0639 \u0630\u0644\u0643\u060c \u062a\u0634\u0643\u0644 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u0639\u062f\u064a\u0629 \u0645\u062b\u0644 \u0645\u0631\u0636 \u0646\u064a\u0648\u0643\u0627\u0633\u0644 (ND)\u060c \u0648\u0627\u0644\u0625\u0646\u0641\u0644\u0648\u0646\u0632\u0627 \u0627\u0644\u0637\u064a\u0648\u0631 (AI)\u060c \u0648\u0627\u0644\u0645\u064a\u0643\u0648\u0628\u0644\u0627\u0632\u0645\u0627 (Mycoplasmosis) \u062a\u0647\u062f\u064a\u062f\u0627\u062a \u0643\u0628\u064a\u0631\u0629. \u0648 \u064a\u0638\u0644 \u0627\u0644\u062a\u0637\u0639\u064a\u0645 \u0627\u0644\u0631\u0643\u064a\u0632\u0629 \u0627\u0644\u0623\u0633\u0627\u0633\u064a\u0629 \u0644\u0645\u0643\u0627\u0641\u062d\u0629 \u0627\u0644\u0623\u0645\u0631\u0627\u0636\u060c \u0644\u0643\u0646 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062a\u0642\u0644\u064a\u062f\u064a\u0629 \u063a\u0627\u0644\u0628\u064b\u0627 \u0645\u0627 \u062a\u0641\u0634\u0644 \u0641\u064a \u0645\u0648\u0627\u062c\u0647\u0629 \u0627\u0644\u062a\u062d\u062f\u064a\u0627\u062a \u0627\u0644\u0646\u0627\u0634\u0626\u0629\u060c \u0628\u0645\u0627 \u0641\u064a \u0630\u0644\u0643 \u0627\u0644\u062a\u0646\u0648\u0639 \u0627\u0644\u062c\u064a\u0646\u064a (Genetic diversity) \u0628\u064a\u0646 \u0645\u0633\u0628\u0628\u0627\u062a \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0648 \u0639\u062f\u0645 \u0625\u0633\u062a\u0642\u0631\u0627\u0631 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0641\u064a \u0627\u0644\u0638\u0631\u0648\u0641 \u0627\u0644\u0645\u064a\u062f\u0627\u0646\u064a\u0629. \u064a\u0633\u062a\u0639\u0631\u0636 \u0647\u0630\u0627 \u0627\u0644\u062a\u0642\u0631\u064a\u0631 \u0627\u0644\u0627\u0628\u062a\u0643\u0627\u0631\u0627\u062a \u0641\u064a \u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0627\u0644\u062a\u064a \u062a\u0639\u0632\u0632 \u062a\u0637\u0648\u064a\u0631 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0648 \u0643\u0641\u0627\u0621\u062a\u0647\u0627 \u0648 \u062a\u0648\u0635\u064a\u0644\u0647\u0627.<\/p>\n

 <\/p>\n

\u0627\u0644\u062a\u0642\u062f\u0645 \u0641\u064a \u062a\u0637\u0648\u064a\u0631 \u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062f\u0648\u0627\u062c\u0646<\/p>\n

    \n
  1. \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062a\u0642\u0644\u064a\u062f\u064a\u0629 \u060c \u0627\u0644\u062c\u06cc\u0644 \u0627\u0644\u0627\u0648\u0644<\/li>\n<\/ol>\n

    \u0643\u0627\u0646\u062a \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062d\u064a\u0629 \u0627\u0644\u0645\u0636\u0639\u0641\u0629 (Live attenuated vaccines) \u0648\u0627\u0644\u0645\u0642\u062a\u0648\u0644\u0629 (Inactivated vaccines) \u0647\u064a \u0627\u0644\u0623\u0633\u0627\u0633 \u0644\u062a\u062d\u0635\u064a\u0646 \u0627\u0644\u062f\u0648\u0627\u062c\u0646 \u0644\u0641\u062a\u0631\u0629 \u0637\u0648\u064a\u0644\u0629. \u0648\u0645\u0639 \u0630\u0644\u0643 \u0641\u0647\u064a \u0645\u0642\u06cc\u062f\u0629\u060c \u062a\u0634\u0645\u0644 \u0642\u064a\u0648\u062f\u0647\u0627:<\/p>\n

    \u062e\u0637\u0631 \u0639\u0648\u062f\u0629 \u0627\u0644\u0641\u064a\u0631\u0648\u0633 \u0625\u0644\u0649 \u062d\u0627\u0644\u062a\u0647 \u0627\u0644\u0636\u0627\u0631\u064a\u0629 (Reversion to virulence) \u0641\u064a \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062d\u064a\u0629 \u0627\u0644\u0645\u0636\u0639\u0641\u0629.<\/p>\n

    \u0625\u0646\u062e\u0641\u0627\u0636 \u0627\u0644\u0643\u0641\u0627\u0621\u0629 \u0628\u0633\u0628\u0628 \u0627\u0644\u062a\u0628\u0627\u064a\u0646 \u0627\u0644\u0645\u0633\u062a\u0636\u062f\u064a \u0645\u0639 \u0627\u0644\u0633\u0644\u0627\u0644\u0627\u062a \u0627\u0644\u062d\u0642\u0644\u064a\u0629 (Antigenic mismatch).<\/p>\n

    \u062a\u062d\u062f\u064a\u0627\u062a \u0627\u0644\u062a\u062e\u0632\u064a\u0646\u060c \u062e\u0627\u0635\u0629 \u0628\u0627\u0644\u0646\u0633\u0628\u0629 \u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u0645\u0642\u062a\u0648\u0644\u0629 \u0627\u0644\u062a\u064a \u062a\u062a\u0637\u0644\u0628 \u0633\u0644\u0633\u0644\u0629 \u062a\u0628\u0631\u064a\u062f (Cold chain).<\/p>\n

     <\/p>\n

      \n
    1. \u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062c\u064a\u0644 \u0627\u0644\u062b\u0627\u0646\u064a (Second-Generation Vaccines)<\/li>\n<\/ol>\n

      \u062a\u0645\u062b\u0644 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u0645\u0624\u062a\u0644\u0641\u0629 (Recombinant vaccines) \u0648 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062c\u0632\u0626\u064a\u0629 (Subunit vaccines) \u062a\u0637\u0648\u0631\u0627\u062a \u0643\u0628\u064a\u0631\u0629 \u0645\u0646 \u062e\u0644\u0627\u0644 \u0625\u0633\u062a\u0647\u062f\u0627\u0641 \u0645\u0633\u062a\u0636\u062f\u0627\u062a \u0645\u062d\u062f\u062f\u0629\u060c \u0648 \u064a\u0645\u0643\u0646 \u0644\u0647\u0630\u0647 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a:<\/p>\n

      \u0627\u0644\u0642\u0636\u0627\u0621 \u0639\u0644\u0649 \u0627\u0644\u0645\u062e\u0627\u0637\u0631 \u0627\u0644\u0645\u0631\u062a\u0628\u0637\u0629 \u0628\u0627\u0644\u0643\u0627\u0626\u0646\u0627\u062a \u0627\u0644\u062d\u064a\u0629 \u0627\u0644\u062d\u064a\u0629 (Live organisms).<\/p>\n

      \u062a\u0642\u062f\u064a\u0645 \u0645\u0631\u0648\u0646\u0629 \u0641\u064a \u062a\u0631\u0643\u064a\u0628 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062a\u0643\u0627\u0641\u0624 (Multivalent vaccines).<\/p>\n

      \u0648\u0645\u0639 \u0630\u0644\u0643\u060c \u064a\u062d\u062f \u0627\u0644\u0627\u0639\u062a\u0645\u0627\u062f \u0639\u0644\u0649 \u0627\u0644\u0645\u062d\u0641\u0632\u0627\u062a (Adjuvants) \u0648\u062a\u0643\u0627\u0644\u064a\u0641 \u0627\u0644\u0625\u0646\u062a\u0627\u062c \u0627\u0644\u0645\u0631\u062a\u0641\u0639\u0629 \u0645\u0646 \u0627\u0646\u062a\u0634\u0627\u0631\u0647\u0627 \u0639\u0644\u0649 \u0646\u0637\u0627\u0642 \u0648\u0627\u0633\u0639.<\/p>\n

       <\/p>\n

        \n
      1. \u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062c\u064a\u0644 \u0627\u0644\u062b\u0627\u0644\u062b (Third-Generation Vaccines)<\/li>\n<\/ol>\n

        \u0638\u0647\u0631\u062a \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u0642\u0627\u0626\u0645\u0629 \u0639\u0644\u0649 \u0627\u0644\u0623\u062d\u0645\u0627\u0636 \u0627\u0644\u0646\u0648\u0648\u064a\u0629 (Nucleic acid-based vaccines)\u060c \u0628\u0645\u0627 \u0641\u064a \u0630\u0644\u0643 \u0627\u0644\u062d\u0645\u0636 \u0627\u0644\u0646\u0648\u0648\u064a \u0627\u0644\u0631\u064a\u0628\u064a (mRNA) \u0648 \u0627\u0644\u062d\u0645\u0636 \u0627\u0644\u0646\u0648\u0648\u064a \u0627\u0644\u0631\u064a\u0628\u0648\u0632\u064a \u0645\u0646\u0642\u0648\u0635 \u0627\u0644\u0623\u0643\u0633\u062c\u064a\u0646 (DNA)\u060c \u0643\u0623\u062f\u0648\u0627\u062a \u062a\u062d\u0648\u0644\u064a\u0629. \u0648 \u062a\u0634\u0645\u0644 \u0627\u0644\u0645\u0632\u0627\u064a\u0627 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629 \u0645\u0627\u06cc\u0644\u064a :<\/p>\n

        \u062c\u062f\u0648\u0644\u0629 \u0625\u0646\u062a\u0627\u062c \u0633\u0631\u064a\u0639\u0629 (Rapid production timelines)\u060c \u0648\u0647\u064a \u0623\u0645\u0631 \u062d\u064a\u0648\u064a \u0623\u062b\u0646\u0627\u0621 \u062a\u0641\u0634\u064a \u0627\u0644\u0623\u0645\u0631\u0627\u0636.<\/p>\n

        \u0645\u0644\u0641\u0627\u062a \u062a\u0639\u0631\u064a\u0641 \u0623\u0645\u0627\u0646 \u0648 \u0645\u062d\u0633\u0646\u0629 (Enhanced safety profiles) \u0628\u0633\u0628\u0628 \u063a\u064a\u0627\u0628 \u0627\u0644\u0643\u0627\u0626\u0646\u0627\u062a \u0627\u0644\u062d\u064a\u0629.<\/p>\n

        \u0627\u0644\u0642\u062f\u0631\u0629 \u0639\u0644\u0649 \u0627\u0644\u062a\u062e\u0635\u064a\u0635 \u0644\u062a\u062a\u0646\u0627\u0633\u0628 \u0645\u0639 \u0633\u0644\u0627\u0644\u0627\u062a \u0645\u0633\u0628\u0628\u0627\u062a \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u062d\u0644\u064a\u0629.<\/p>\n

         <\/p>\n

        \u0627\u0644\u062a\u0642\u0646\u064a\u0627\u062a \u0627\u0644\u0645\u0628\u062a\u0643\u0631\u0629 \u0644\u0644\u0645\u062d\u0641\u0632\u0627\u062a (Adjuvants)<\/p>\n

        \u0644\u0642\u062f \u0633\u0627\u0647\u0645 \u062a\u0637\u0648\u064a\u0631 \u0627\u0644\u0645\u062d\u0641\u0632\u0627\u062a \u0627\u0644\u0645\u062a\u0642\u062f\u0645\u0629 \u0641\u064a \u062a\u062d\u0633\u064a\u0646 \u0643\u0641\u0627\u0621\u0629 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0628\u0634\u0643\u0644 \u0643\u0628\u064a\u0631\u060c \u0648\u062a\u0634\u0645\u0644 \u0627\u0644\u0623\u0645\u062b\u0644\u0629:<\/p>\n

        \u0627\u0644\u062c\u0633\u064a\u0645\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u064a\u0629 (Nanoparticles): \u0627\u0644\u062a\u064a \u062a\u0639\u0645\u0644 \u0643\u0646\u0627\u0642\u0644\u0627\u062a \u0648\u0645\u062d\u0641\u0632\u0627\u062a \u0645\u0646\u0627\u0639\u064a\u0629 (Immune stimulants).<\/p>\n

        \u0645\u062d\u0641\u0632\u0627\u062a \u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a (TLR Agonists): \u0627\u0644\u062a\u064a \u062a\u0639\u0632\u064a\u0632 \u0627\u0644\u0627\u0633\u062a\u062c\u0627\u0628\u0627\u062a \u0627\u0644\u0645\u0646\u0627\u0639\u064a\u0629 \u0627\u0644\u0641\u0637\u0631\u064a\u0629.<\/p>\n

        \u0627\u0644\u0645\u062d\u0641\u0632\u0627\u062a \u0627\u0644\u0642\u0627\u0626\u0645\u0629 \u0639\u0644\u0649 \u0627\u0644\u0645\u0633\u062a\u062d\u0644\u0628 (Emulsion-Based Adjuvants): \u0627\u0644\u062a\u064a \u062a\u0648\u0641\u0631 \u0627\u0644\u0627\u0633\u062a\u0642\u0631\u0627\u0631 \u0648\u0625\u0637\u0644\u0627\u0642 \u0627\u0644\u0645\u0633\u062a\u0636\u062f \u0628\u0634\u0643\u0644 \u0645\u0637\u0648\u0644.<\/p>\n

        \u062a\u0633\u0627\u0639\u062f \u06a9\u0644 \u0647\u0630\u0647 \u0627\u0644\u0645\u062d\u0641\u0632\u0627\u062a \u0641\u064a \u0625\u062d\u062f\u0627\u062b \u0645\u0646\u0627\u0639\u0629 \u0642\u0648\u064a\u0629 \u0648\u0637\u0648\u064a\u0644\u0629 \u0627\u0644\u0623\u0645\u062f \u0645\u0639 \u062a\u0642\u0644\u064a\u0644 \u0627\u0644\u062a\u0641\u0627\u0639\u0644\u0627\u062a \u0627\u0644\u0633\u0644\u0628\u064a\u0629.<\/p>\n

         <\/p>\n

        \u0625\u0628\u062a\u0643\u0627\u0631\u0627\u062a \u0627\u0644\u062a\u0648\u0635\u064a\u0644 (Delivery Innovations)<\/p>\n

        \u062a\u0639\u0645\u0644 \u0623\u0646\u0638\u0645\u0629 \u0627\u0644\u062a\u0648\u0635\u064a\u0644 \u0627\u0644\u062d\u062f\u064a\u062b\u0629 \u0639\u0644\u0649 \u062a\u062d\u0633\u064a\u0646 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0648\u062a\u0639\u0632\u064a\u0632 \u0643\u0641\u0627\u0621\u062a\u0647\u0627 \u0641\u064a \u0627\u0644\u0645\u064a\u0627\u062f\u06cc\u0646 \u0627\u0644\u062a\u0627\u0644\u06cc\u0629 :<\/p>\n

        \u0627\u0644\u062a\u0644\u0642\u064a\u062d \u062f\u0627\u062e\u0644 \u0627\u0644\u0628\u064a\u0636 (In Ovo Vaccination): \u062a\u0642\u0646\u064a\u0629 \u062a\u062d\u0635\u064a\u0646 \u0627\u0644\u0623\u062c\u0646\u0629 \u0642\u0628\u0644 \u0627\u0644\u0641\u0642\u0633\u060c \u0645\u0645\u0627 \u064a\u0636\u0645\u0646 \u0627\u0644\u062d\u0645\u0627\u064a\u0629 \u0627\u0644\u0645\u0628\u0643\u0631\u0629.<\/p>\n

        \u0627\u0644\u062a\u0648\u0635\u064a\u0644 \u0628\u0627\u0644\u0631\u0634 \u0648\u0627\u0644\u0647\u0628\u0627\u0621 \u0627\u0644\u062c\u0648\u064a (Spray and Aerosol Delivery): \u064a\u064f\u0633\u062a\u062e\u062f\u0645 \u0639\u0644\u0649 \u0646\u0637\u0627\u0642 \u0648\u0627\u0633\u0639 \u0644\u0644\u062a\u062d\u0635\u064a\u0646 \u0627\u0644\u062c\u0645\u0627\u0639\u064a \u0641\u064a \u0627\u0644\u0645\u0632\u0627\u0631\u0639 \u0627\u0644\u062a\u062c\u0627\u0631\u064a\u0629.<\/p>\n

        \u0627\u0644\u0646\u0627\u0642\u0644\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u064a\u0629 (Nanoparticle-Based Carriers): \u062a\u062d\u0645\u064a \u0627\u0644\u0645\u0633\u062a\u0636\u062f\u0627\u062a \u0645\u0646 \u0627\u0644\u062a\u062d\u0644\u0644 \u0648\u062a\u0633\u0647\u0644 \u0627\u0644\u062a\u0648\u0635\u064a\u0644 \u0627\u0644\u0645\u0633\u062a\u0647\u062f\u0641 \u0625\u0644\u0649 \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u0645\u0646\u0627\u0639\u064a\u0629.<\/p>\n

        \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062d\u0631\u0627\u0631\u064a\u0629 (Thermostable Vaccines): \u062a\u062a\u063a\u0644\u0628 \u0639\u0644\u0649 \u0627\u0644\u0627\u0639\u062a\u0645\u0627\u062f \u0639\u0644\u0649 \u0627\u0644\u0644\u0648\u062c\u0633\u062a\u064a\u0627\u062a \u0627\u0644\u0628\u0627\u0631\u062f\u0629 \u0645\u0646 \u062e\u0644\u0627\u0644 \u0627\u0644\u062d\u0641\u0627\u0638 \u0639\u0644\u0649 \u0627\u0644\u0643\u0641\u0627\u0621\u0629 \u062a\u062d\u062a \u0638\u0631\u0648\u0641 \u0627\u0644\u062a\u062e\u0632\u064a\u0646 \u0627\u0644\u0645\u062a\u063a\u064a\u0631\u0629.<\/p>\n

         <\/p>\n

        \u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0641\u064a \u062a\u062d\u062f\u064a\u062f \u0645\u0633\u0628\u0628\u0627\u062a \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0648\u062a\u0635\u0645\u064a\u0645 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a<\/p>\n

        \u0644\u0642\u062f \u062d\u0633\u0646\u062a \u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0645\u0646 \u062a\u0648\u0635\u064a\u0641 \u0645\u0633\u0628\u0628\u0627\u062a \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0645\u0646 \u062e\u0644\u0627\u0644 \u062a\u0633\u0644\u0633\u0644 \u0627\u0644\u062c\u064a\u0646\u0648\u0645 (Genome Sequencing) \u0648\u0639\u0644\u0645 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u0639\u0643\u0633\u064a (Reverse Vaccinology). \u062a\u062a\u064a\u062d \u0647\u0630\u0647 \u0627\u0644\u0623\u062f\u0648\u0627\u062a \u062a\u062d\u062f\u064a\u062f \u0623\u0647\u062f\u0627\u0641 \u0645\u0633\u062a\u0636\u062f\u064a\u0629 \u0645\u062d\u0641\u0648\u0638\u0629\u060c \u0645\u0645\u0627 \u064a\u0642\u0644\u0644 \u0645\u0646 \u0645\u062e\u0627\u0637\u0631 \u0627\u0644\u062a\u0628\u0627\u064a\u0646 \u0627\u0644\u0645\u0633\u062a\u0636\u062f\u064a. \u062a\u0633\u0631\u0639 \u062a\u0637\u0628\u064a\u0642\u0627\u062a \u0643\u0631\u064a\u0633\u0628\u0631 (CRISPR) \u0648 \u0627\u0644\u0645\u0639\u0644\u0648\u0645\u0627\u062a\u064a\u0629 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 (Bioinformatics) \u0623\u064a\u0636\u064b\u0627 \u062a\u0635\u0645\u064a\u0645 \u0644\u0642\u0627\u062d\u0627\u062a \u062f\u0642\u064a\u0642\u0629 \u0648 \u0641\u0639\u0627\u0644\u0629.<\/p>\n

         <\/p>\n

        \u0627\u0644\u062a\u062d\u062f\u064a\u0627\u062a \u0627\u0644\u062d\u0627\u0644\u064a\u0629 (Challenges)<\/p>\n

        \u0639\u0644\u0649 \u0627\u0644\u0631\u063a\u0645 \u0645\u0646 \u0627\u0644\u062a\u0642\u062f\u0645 \u0627\u0644\u0643\u0628\u064a\u0631\u060c \u0644\u0627 \u062a\u0632\u0627\u0644 \u0647\u0646\u0627\u0643 \u0627\u0644\u06a9\u062b\u06cc\u0631 \u0645\u0646 \u0639\u0642\u0628\u0627\u062a \u0648 \u0627\u0644\u062a\u064a \u062a\u0634\u0645\u0644 :<\/p>\n

        \u062a\u0646\u0648\u0639 \u0645\u0633\u0628\u0628\u0627\u062a \u0627\u0644\u0623\u0645\u0631\u0627\u0636 (Pathogen Diversity): \u062a\u0624\u062f\u064a \u0645\u0639\u062f\u0644\u0627\u062a \u0627\u0644\u0637\u0641\u0631\u0627\u062a \u0627\u0644\u0639\u0627\u0644\u064a\u0629 \u0641\u064a \u0627\u0644\u0641\u064a\u0631\u0648\u0633\u0627\u062a \u0645\u062b\u0644 \u0627\u0644\u0625\u0646\u0641\u0644\u0648\u0646\u0632\u0627 \u0625\u0644\u0649 \u062a\u0639\u0642\u064a\u062f \u062a\u0635\u0645\u064a\u0645 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a.<\/p>\n

        \u0627\u0644\u0627\u0633\u062a\u0642\u0631\u0627\u0631 \u0627\u0644\u0645\u064a\u062f\u0627\u0646\u064a (Field Stability): \u064a\u062c\u0628 \u0623\u0646 \u062a\u062a\u062d\u0645\u0644 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u0638\u0631\u0648\u0641 \u0627\u0644\u0628\u064a\u0626\u064a\u0629 \u0627\u0644\u0635\u0639\u0628\u0629 \u0641\u064a \u0627\u0644\u0645\u0646\u0627\u0637\u0642 \u0627\u0644\u0646\u0627\u0645\u064a\u0629.<\/p>\n

        \u0642\u064a\u0648\u062f \u0627\u0644\u062a\u0643\u0644\u0641\u0629 (Cost Constraints): \u062a\u0638\u0644 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u0645\u062a\u0642\u062f\u0645\u0629 \u0648\u0627\u0644\u0645\u062d\u0641\u0632\u0627\u062a \u0628\u0627\u0647\u0638\u0629 \u0627\u0644\u062b\u0645\u0646 \u0628\u0627\u0644\u0646\u0633\u0628\u0629 \u0644\u0644\u0645\u0632\u0627\u0631\u0639\u064a\u0646 \u0627\u0644\u0635\u063a\u0627\u0631.<\/p>\n

         <\/p>\n

         <\/p>\n

        \"\"<\/p>\n

        7. \u0627\u0644\u062a\u0648\u062c\u0647\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u0642\u0628\u0644\u064a\u0629<\/p>\n

        \u0644\u0645\u0648\u0627\u062c\u0647\u0629 \u0647\u0630\u0647 \u0627\u0644\u062a\u062d\u062f\u064a\u0627\u062a\u060c \u064a\u062c\u0628 \u0623\u0646 \u062a\u0631\u0643\u0632 \u0627\u0644\u0623\u0628\u062d\u0627\u062b \u0627\u0644\u0645\u0633\u062a\u0642\u0628\u0644\u064a\u0629 \u0639\u0644\u0649:<\/p>\n

        \u062a\u0637\u0648\u064a\u0631 \u0644\u0642\u0627\u062d\u0627\u062a \u0634\u0627\u0645\u0644\u0629 (Universal Vaccines) \u062a\u0633\u062a\u0647\u062f\u0641 \u0627\u0644\u0645\u0633\u062a\u0636\u062f\u0627\u062a \u0627\u0644\u0645\u062d\u0641\u0648\u0638\u0629 \u0639\u0628\u0631 \u0633\u0644\u0627\u0644\u0627\u062a \u0645\u0633\u0628\u0628\u0627\u062a \u0627\u0644\u0623\u0645\u0631\u0627\u0636.<\/p>\n

        \u062a\u062d\u0633\u064a\u0646 \u0627\u0644\u0627\u0633\u062a\u0642\u0631\u0627\u0631 \u0627\u0644\u062d\u0631\u0627\u0631\u064a \u0644\u0644\u0642\u0627\u062d\u0627\u062a (Thermostability) \u0644\u0646\u0634\u0631\u0647\u0627 \u0641\u064a \u0627\u0644\u0645\u0646\u0627\u0637\u0642 \u0630\u0627\u062a \u0627\u0644\u0645\u0648\u0627\u0631\u062f \u0627\u0644\u0645\u062d\u062f\u0648\u062f\u0629.<\/p>\n

        \u0625\u0633\u062a\u0643\u0634\u0627\u0641 \u062a\u0635\u0645\u064a\u0645 \u0627\u0644\u0644\u0642\u0627\u062d\u0627\u062a \u0628\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0630\u0643\u0627\u0621 \u0627\u0644\u0627\u0635\u0637\u0646\u0627\u0639\u064a (AI) \u0644\u0644\u062a\u0646\u0628\u0624 \u0628\u0645\u0633\u0628\u0628\u0627\u062a \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0646\u0627\u0634\u0626\u0629.<\/p>\n

        \u062a\u0648\u0633\u064a\u0639 \u0637\u0631\u0642 \u0627\u0644\u0625\u0646\u062a\u0627\u062c \u0644\u062e\u0641\u0636 \u0627\u0644\u062a\u0643\u0627\u0644\u064a\u0641 \u062f\u0648\u0646 \u0627\u0644\u0645\u0633\u0627\u0633 \u0628\u0627\u0644\u0643\u0641\u0627\u0621\u0629.<\/p>\n

         <\/p>\n

        \u0627\u0644\u0627\u0633\u062a\u0646\u062a\u0627\u062c<\/p>\n

        \u0623\u062f\u062e\u0644\u062a \u0627\u0644\u062a\u0637\u0648\u0631\u0627\u062a \u0641\u064a \u0627\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0639\u0635\u0631\u064b\u0627 \u062c\u062f\u064a\u062f\u064b\u0627 \u0644\u062a\u0637\u0648\u064a\u0631 \u0644\u0642\u0627\u062d\u0627\u062a \u0627\u0644\u062f\u0648\u0627\u062c\u0646\u060c \u0645\u0645\u0627 \u064a\u0639\u0627\u0644\u062c \u0627\u0644\u062a\u062d\u062f\u064a\u0627\u062a \u0627\u0644\u0642\u062f\u064a\u0645\u0629 \u0627\u0644\u0645\u062a\u0639\u0644\u0642\u0629 \u0628\u0627\u0644\u0627\u0633\u062a\u0642\u0631\u0627\u0631 \u0648\u0627\u0644\u0643\u0641\u0627\u0621\u0629 \u0648 \u0627\u0644\u062a\u0648\u0635\u064a\u0644. \u0648 \u0645\u0639 \u0625\u0633\u062a\u0645\u0631\u0627\u0631 \u0632\u064a\u0627\u062f\u0629 \u0627\u0644\u0637\u0644\u0628 \u0627\u0644\u0639\u0627\u0644\u0645\u064a \u0639\u0644\u0649 \u0645\u0646\u062a\u062c\u0627\u062a \u0627\u0644\u062f\u0648\u0627\u062c\u0646\u060c \u0633\u062a\u0643\u0648\u0646 \u0647\u0630\u0647 \u0627\u0644\u0627\u0628\u062a\u0643\u0627\u0631\u0627\u062a \u062d\u0627\u0633\u0645\u0629 \u0644\u062d\u0645\u0627\u064a\u0629 \u0635\u062d\u0629 \u0627\u0644\u062d\u064a\u0648\u0627\u0646\u0627\u062a \u0648\u0636\u0645\u0627\u0646 \u0627\u0644\u0625\u0646\u062a\u0627\u062c \u0627\u0644\u0645\u0633\u062a\u062f\u0627\u0645. \u064a\u062a\u0637\u0644\u0628 \u062a\u0631\u062c\u0645\u0629 \u0647\u0630\u0647 \u0627\u0644\u0627\u0628\u062a\u0643\u0627\u0631\u0627\u062a \u0625\u0644\u0649 \u062a\u0637\u0628\u064a\u0642\u0627\u062a \u0645\u064a\u062f\u0627\u0646\u064a\u0629 \u0648\u0627\u0633\u0639\u0629 \u0627\u0644\u0646\u0637\u0627\u0642 \u062c\u0647\u0648\u062f\u064b\u0627 \u062a\u0639\u0627\u0648\u0646\u064a\u0629 \u0628\u064a\u0646 \u0627\u0644\u0628\u0627\u062d\u062b\u064a\u0646 \u0648\u0623\u0635\u062d\u0627\u0628 \u0627\u0644\u0645\u0635\u0644\u062d\u0629 \u0641\u064a \u0627\u0644\u0635\u0646\u0627\u0639\u0629 \u0648\u0635\u0646\u0627\u0639 \u0627\u0644\u0633\u064a\u0627\u0633\u0627\u062a.<\/p>","protected":false},"excerpt":{"rendered":"

        Innovations in Poultry Vaccine Development: Addressing Challenges in Stability, Efficacy, […]<\/p>","protected":false},"author":1,"featured_media":4421,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,75],"tags":[],"class_list":["post-4420","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-news"],"_links":{"self":[{"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/posts\/4420","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/comments?post=4420"}],"version-history":[{"count":0,"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/posts\/4420\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/media\/4421"}],"wp:attachment":[{"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/media?parent=4420"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/categories?post=4420"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nahrainveterinary.com\/ar\/wp-json\/wp\/v2\/tags?post=4420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}